{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:03:12Z","timestamp":1788357792193,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00415-019-09618-0","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T13:03:00Z","timestamp":1573218180000},"page":"561-571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic factor of poor outcome in anti-MAG neuropathy: clinical and electrophysiological analysis of a French Cohort"],"prefix":"10.1007","volume":"267","author":[{"given":"Marie-Ange Hoang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0775-4625","authenticated-orcid":false,"given":"St\u00e9phane","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duffau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cazenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Soulages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendal","family":"Le Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"key":"9618_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749\u2013757","journal-title":"Br J Haematol"},{"key":"9618_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/bmj.2.4996.802","volume":"2","author":"RS Crow","year":"1956","unstructured":"Crow RS (1956) Peripheral neuritis in myelomatosis. Br Med J 2:802\u2013804","journal-title":"Br Med J"},{"key":"9618_CR3","unstructured":"Victor M, Banker BQ, Adams RD (1955\u20131956) The neuropathy of multiple myeloma. Trans Am Neurol Assoc 99\u2013102"},{"key":"9618_CR4","first-page":"562","volume":"74","author":"R Garcin","year":"1958","unstructured":"Garcin R, Mallarm\u00e9 J, Rondot P (1958) Forme n\u00e9vritique de la macroglobulin\u00e9mie de Waldenstr\u00f6m. Bull Mem Soc Med Hop Paris 74:562\u2013573","journal-title":"Bull Mem Soc Med Hop Paris"},{"key":"9618_CR5","first-page":"979","volume":"158","author":"E Nobile-Orazio","year":"2002","unstructured":"Nobile-Orazio E, Casellato C, Di Troia A (2002) Neuropathies associated with IgG and IgA monoclonal gammopathy. Rev Neurol (Paris) 158:979\u2013987","journal-title":"Rev Neurol (Paris)"},{"key":"9618_CR6","doi-asserted-by":"publisher","first-page":"450391","DOI":"10.1155\/2015\/450391","volume":"2015","author":"L Magy","year":"2015","unstructured":"Magy L, Kabor\u00e9 R, Mathis S, Lebeau P, Ghorab K, Caudie C et al (2015) Heterogeneity of polyneuropathy associated with anti-MAG antibodies. J Immunol Res 2015:450391","journal-title":"J Immunol Res"},{"key":"9618_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1056\/NEJM198009113031105","volume":"303","author":"N Latov","year":"1980","unstructured":"Latov N, Sherman WH, Nemni R, Galassi G, Shyong JS, Penn AS et al (1980) Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med 303:618\u2013621","journal-title":"N Engl J Med"},{"key":"9618_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/brain\/106.1.169","volume":"106","author":"IS Smith","year":"1983","unstructured":"Smith IS, Kahn SN, Lacey BW, King RH, Eames RA, Whybrew DJ et al (1983) Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. Brain 106:169\u2013195","journal-title":"Brain"},{"key":"9618_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/14737175.2018.1489240","volume":"18","author":"S Mathis","year":"2018","unstructured":"Mathis S, Magy L, Le Masson G, Richard L, Soulages A, Sol\u00e9 G et al (2018) Value of nerve biopsy in the management of peripheral neuropathies. Expert Rev Neurother 18:589\u2013602","journal-title":"Expert Rev Neurother"},{"key":"9618_CR10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1471-4159.2006.04319.x","volume":"100","author":"RH Quarles","year":"2007","unstructured":"Quarles RH (2007) Myelin-associated glycoprotein (MAG): past, present and beyond. J Neurochem 100:1431\u20131448","journal-title":"J Neurochem"},{"key":"9618_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/14737175.2016.1198257","volume":"16","author":"JM Vallat","year":"2016","unstructured":"Vallat JM, Magy L, Ciron J, Corcia P, Le Masson G, Mathis S (2016) Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies. Expert Rev Neurother 16:1111\u20131119","journal-title":"Expert Rev Neurother"},{"key":"9618_CR12","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1007\/s00415-018-9081-7","volume":"265","author":"YM Falzone","year":"2018","unstructured":"Falzone YM, Campagnolo M, Bianco M, Dacci P, Martinelli D, Ruiz M et al (2018) Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies. J Neurol 265:2927\u20132933","journal-title":"J Neurol"},{"key":"9618_CR13","first-page":"353","volume":"64","author":"C Caudie","year":"2006","unstructured":"Caudie C, Kaygisiz F, Jaquet P, Petiot P, Gonnaud PM, Antoine JC et al (2006) Les autoanticorps IgM anti-MAG par Elisa Buhlmann: apport diagnostique dans 117 neuropathies p\u00e9riph\u00e9riques auto-immunes associ\u00e9es \u00e0 une IgM monoclonale \u00e0 activit\u00e9 anti-SGPG\/SGLPG. Ann Biol Clin (Paris) 64:353\u2013359","journal-title":"Ann Biol Clin (Paris)"},{"key":"9618_CR14","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","volume":"54","author":"B Farrell","year":"1991","unstructured":"Farrell B, Godwin J, Richards S, Warlow C (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54:1044\u20131054","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9618_CR15","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/mus.1145","volume":"24","author":"D Cocito","year":"2001","unstructured":"Cocito D, Isoardo G, Ciaramitaro P, Migliaretti G, Pipieri A, Barbero P et al (2001) Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody. Muscle Nerve 24:1278\u20131282","journal-title":"Muscle Nerve"},{"key":"9618_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00415-009-5412-z","volume":"257","author":"E Delmont","year":"2010","unstructured":"Delmont E, Jeandel PY, Hubert AM, Marcq L, Boucraut J, Desnuelle C (2010) Successful treatment with rituximab of one patient with CANOMAD neuropathy. J Neurol 257:655\u2013657","journal-title":"J Neurol"},{"key":"9618_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1529-8027.2010.00278.x","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","unstructured":"Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. J Peripher Nerv Syst 15:185\u2013195","journal-title":"J Peripher Nerv Syst"},{"key":"9618_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1529-8027.2010.00245.x","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","unstructured":"Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. J Peripher Nerv Syst 15:1\u20139","journal-title":"J Peripher Nerv Syst"},{"key":"9618_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/brain\/123.4.710","volume":"123","author":"E Nobile-Orazio","year":"2000","unstructured":"Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G (2000) Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 123:710\u2013717","journal-title":"Brain"},{"key":"9618_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF00878529","volume":"243","author":"E Ellie","year":"1996","unstructured":"Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J (1996) Neuropathy associated with \u201cbenign\u201d anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases. J Neurol 243:34\u201343","journal-title":"J Neurol"},{"key":"9618_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jnnp-2017-316715","volume":"89","author":"J Svahn","year":"2018","unstructured":"Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K et al (2018) Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features. J Neurol Neurosurg Psychiatry 89:499\u2013505","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9618_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO;2-F","volume":"21","author":"B Chassande","year":"1998","unstructured":"Chassande B, L\u00e9ger JM, Younes-Chennoufi AB, Bengoufa D, Maisonobe T, Bouche P et al (1998) Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical\/electrophysiological features in 40 cases. Muscle Nerve 21:55\u201362","journal-title":"Muscle Nerve"},{"key":"9618_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF00319857","volume":"238","author":"KB Yeung","year":"1991","unstructured":"Yeung KB, Thomas PK, King RH, Waddy H, Will RG, Hughes RA et al (1991) The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 238:383\u2013391","journal-title":"J Neurol"},{"key":"9618_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ana.410360313","volume":"36","author":"E Nobile-Orazio","year":"1994","unstructured":"Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S et al (1994) Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36:416\u2013424","journal-title":"Ann Neurol"},{"key":"9618_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.neurol.2009.04.008","volume":"165","author":"M Launay","year":"2009","unstructured":"Launay M, Delmont E, Benaim C, Sacconi S, Butori C, Desnuelle C (2009) Les polyneuropathies avec IgM monoclonale anti-MAG: \u00e9tude descriptive clinique, biologique, \u00e9lectrophysiologique et anatomopathologique d\u2019une cohorte de 13 patients. Rev Neurol (Paris) 165:1071\u20131079","journal-title":"Rev Neurol (Paris)"},{"key":"9618_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/ene.13459","volume":"25","author":"YA Rajabally","year":"2018","unstructured":"Rajabally YA, Delmont E, Hiew FL, Aube-Nathier AC, Grapperon AM, Cassereau J et al (2018) Prevalence, correlates and impact of pain and cramps in anti-MAG neuropathy: a multicentre European study. Eur J Neurol 25:135\u2013141","journal-title":"Eur J Neurol"},{"key":"9618_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jns.2006.12.012","volume":"254","author":"S Boukhris","year":"2007","unstructured":"Boukhris S, Magy L, Khalil M, Sindou P, Vallat JM (2007) Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J Neurol Sci 254:33\u201338","journal-title":"J Neurol Sci"},{"key":"9618_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-019-0128-y","author":"A Michaelides","year":"2019","unstructured":"Michaelides A, Hadden RDM, Sarrigiannis PG, Hadjivassiliou M, Zis P (2019) Pain in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Pain Ther. https:\/\/doi.org\/10.1007\/s40122-019-0128-y","journal-title":"Pain Ther"},{"key":"9618_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ana.21577","volume":"65","author":"MC Dalakas","year":"2009","unstructured":"Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R et al (2009) Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol 65:286\u2013293","journal-title":"Ann Neurol"},{"key":"9618_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jns.2017.04.015","volume":"377","author":"S Gazzola","year":"2017","unstructured":"Gazzola S, Delmont E, Franques J, Boucraut J, Salort-Campana E, Verschueren A et al (2017) Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy. J Neurol Sci 377:144\u2013148","journal-title":"J Neurol Sci"},{"key":"9618_CR31","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","volume":"80","author":"JM L\u00e9ger","year":"2013","unstructured":"L\u00e9ger JM, Viala K, Nicolas G, Cr\u00e9ange A, Vallat JM, Pouget J et al (2013) Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy. Neurology 80:2217\u20132225","journal-title":"Neurology"},{"key":"9618_CR32","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s00415-002-0808-z","volume":"249","author":"G Comi","year":"2002","unstructured":"Comi G, Roveri L, Swan A, Willison H, Bojar M, Illa I et al (2002) A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 249:1370\u20131377","journal-title":"J Neurol"},{"key":"9618_CR33","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.clinph.2017.04.022","volume":"128","author":"F Fatehi","year":"2017","unstructured":"Fatehi F, Delmont E, Grapperon AM, Salort-Campana E, Sevy A, Verschueren A et al (2017) Motor unit number index (MUNIX) in patients with anti-MAG neuropathy. Clin Neurophysiol 128:1264\u20131269","journal-title":"Clin Neurophysiol"},{"key":"9618_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/00207454.2016.1191013","volume":"127","author":"G Galassi","year":"2017","unstructured":"Galassi G, Tondelli M, Ariatti A, Benuzzi F, Nichelli P, Valzania F (2017) Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies. Int J Neurosci 127:439\u2013447","journal-title":"Int J Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09618-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T11:46:47Z","timestamp":1721994407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09618-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["9618"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09618-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736885378.793576785","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"assertion":[{"value":"28 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was in compliance with the ethical principles of the conference of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}